Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

General > General - Laatste dingen 2 > Flashcards

General - Laatste dingen 2 Flashcards

1
Q

Pseudomonas commensal bacterial keratitis
a. true
b. false

A

b. false

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Radiation best outcome in sarcoids
a. true
b. false

A

a. true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Corneal stromal degeneration
a. MMP-1, MMP-3, serine proteases
b. MMP-1, MMP-3, choline proteases
c. MMP-2, MMP-9, serine proteases
d. MMP-2, MMP-6, choline proteases

A

c. MMP-2, MMP-9, serine proteases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Doxycycline –> less activity of MMP
a. true
b. false

A

a. true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Afferent PLR
a. II
b. III
c. VI

A

a. II

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Efferent PLR
a. II
b. III
c. VI

A

b. III

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

ERU
a. TH1
b. TH2
c. TH17

A

a. TH1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Optic disk
a. tapetal
b. non-tapetal

A

b. non-tapetal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

B-blockers and carbonic anhydrase inhibitors
a. decrease aqueuos production
b. increase aqueous outflow

A

a. decrease aqueuos production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Insulin in geriatric donkeys (like horses)
a. lower
b. same
c. higher

A

c. lower

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Glucose-curve donkeys
a. right shifted
b. left shifted

A

a. right shifted

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Leptin in older and in fat donkeys
a. lower
b. same
c. higher

A

c. higher

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

T3/T4 in donkeys
a. lower
b. same
c. higher

A

c. higher

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Phenylbutazone vs. thyroid hormones
a. lower
b. same
c. higher

A

a. lower

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Corticosteroids vs. thyroid hormones
a. lower
b. same
c. higher

A

a. lower

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Phenylbutazone in miniature donkeys
a. shorter half-life
b. same half-life
c. longer half-life

A

a. shorter half-life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Polyurethane or polypropylene
a. polyurethane
b. polypropylene

A

a. polyurethane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Maintenance fluids vs. replacement crystalloids
a. higher Ca/P/Mg
b. same Ca/P/Mg
c. lower Ca/P/Mg

A

a. higher Ca/P/Mg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Replacement fluid vs. maintenance fluids
a. Higher Na/Cl
b. Same Na/Cl
c. Lower Na/Cl

A

a. Higher Na/Cl

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Long-term fluid therapy BEss
a. high Na/K, low Mg/Ca
b. high Na, low K/Mg/Ca
c. low Na/K/Mg/Ca
d. high Na/K/Mg/Ca

A

b. high Na, low K/Mg/Ca

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

ECF and VS
a. ECF 20%, VS 5%
b. ECF 30%, VS 8%
c. ECF 35%, VS 10%
d. ECF 40%, VS 12%

A

b. ECF 30%, VS 8%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

LRS vs. plasma
a. Lower Na/Cl
b. Lower Na, higher Cl
c. Higher Na/Cl
d. Higher Na, lower Cl

A

b. Lower Na, higher Cl

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

PF abdominal surgery no enterotomy
a. WBC increase 1-4 days, normal 14 days
b. WBC increase 1-4 days, normal 28 days
c. WBC increase 4-7 days, normal 14 days
d. WBC increase 4-7 days, normal 28 days

A

c. WBC increase 4-7 days, normal 14 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

PF abdominal surgery with enterotomy
a. WBC increase 4-7 days, normal 14 days
b. WBC increase 4-7 days, normal 28 days
c. WBC increase 1-4 days, normal 14 days
d. WBC increase 1-4 days, normal 28 days

A

a. WBC increase 4-7 days, normal 14 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

PF abdominal surgery with or without enterotomy
a. Protein high for 1 week
b. Protein high for 2 weeks
c. Protein high for 3 weeks
d. Protein high for 4 weeks

A

d. Protein high for 4 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Alpha-1
a. chronotropic/inotropic
b. inotropic + peripheral vasoconstriction
c. vasodilation
d. chronotropic/inotropic + vasodilation

A

b. inotropic + peripheral vasoconstriction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Post-synaptic alpha-2
a. chronotropic/inotropic
b. inotropic + peripheral vasoconstriction
c. vasodilation
d. chronotropic/inotropic + vasodilation

A

c. vasodilation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

B1
a. chronotropic/inotropic
b. inotropic + peripheral vasoconstriction
c. vasodilation
d. chronotropic/inotropic + vasodilation

A

a. chronotropic/inotropic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

B2
a. chronotropic/inotropic
b. inotropic + peripheral vasoconstriction
c. vasodilation
d. chronotropic/inotropic + vasodilation

A

d. chronotropic/inotropic + vasodilation (ONLY SOME CHRONOTROPHY/INOTROPHY)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Physiologic dead space
a. upper airways and respiratory passageways
b. areas not equally perfused and ventilated

A

b. areas not equally perfused and ventilated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Anatomic dead space
a. upper airways and respiratory passageways
b. areas not equally perfused and ventilated

A

a. upper airways and respiratory passageways

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Pa <100 mm Hg after therapy
a. Pulmonary thromboembolism
b. Left-to-right-shunting
c. V/Q mismatch
d. Diffusion disturbance

A

a. Pulmonary thromboembolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Pa <100 mm Hg after therapy
a. Pneumonia
b. Right-to-left-shunting
c. V/Q mismatch
d. Diffusion disturbance

A

b. Right-to-left-shunting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

DPG
a. increase in undersaturation
b. decrease in undersaturation
c. increase in low PaO2
d. decrease in low PaO2

A

a. increase in undersaturation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Hypoxemia
a. low oxygen in blood
b. low oxygen in tissues

A

a. low oxygen in blood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Hypoxia
a. low oxygen in blood
b. low oxygen in tissues

A

b. low oxygen in tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Hydrophobic surfactant proteins
a. SP-B and SP-C
b. SP-A and SP-D

A

a. SP-B and SP-C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Hydrophilic surfactant proteins
a. SP-B and SP-C
b. SP-A and SP-D

A

b. SP-A and SP-D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Maxillary artery
a. Medial compartment
b. Lateral compartment

A

b. Lateral compartment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Biggest compartment
a. Medial compartment
b. Lateral compartment

A

a. Medial compartment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Mycotic plaques
a. External maxillary artery
b. Internal carotid artery
c. External carotid artery

A

b. Internal carotid artery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Mycotic plaques
a. roof medial compartment
b. lateral wall lateral compartment

A

a. roof medial compartment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Internal carotid artery
a. Medial compartment
b. Lateral compartment

A

a. Medial compartment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

External carotid artery
a. Medial compartment
b. Lateral compartment

A

b. Lateral compartment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Purpura hemorrhagica
a. type I
b. type II
c. type III
d. type IV

A

c. type III

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

AHS - peracute
a. Pulmonary
b. Cardiac and pulmonary
c. Myocardial

A

a. Pulmonary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

AHS - acute
a. Pulmonary
b. Cardiac and pulmonary
c. Myocardial

A

b. Cardiac and pulmonary

48
Q

Type I pneumocytes
a. secrete surfactant proteins
b. line alveolar surface

A

b. line alveolar surface

49
Q

Type II pneumocytes
a. secrete surfactant proteins
b. line alveolar surface

A

a. secrete surfactant proteins

50
Q

Type I pneumocytes
a. flat and thin
b. cubic

A

a. flat and thin

51
Q

Type II pneumocytes
a. flat and thin
b. cubic

52
Q

Muscle type 1 fiber
a. lower glycogen and glycolytic capacity
b. lower lipid and oxidative capacity

A

a. lower glycogen and glycolytic capacity

53
Q

Muscle type 1 fiber
a. higher glycogen and glycolytic capacity
b. higher lipid and oxidative capacity

A

b. higher lipid and oxidative capacity

54
Q

Dantrolene sodium
a. decrease release of Ca from SR
b. increase release of Ca from SR

A

a. decrease release of Ca from SR

55
Q

Acute rhabdomyolysis
a. low Na/Cl/K
b. low Na/Cl, high K
c. high Na/Cl, low K
d. high Na/Cl/K

A

b. low Na/Cl, high K

56
Q

PSSM-1
a. amylase resistant
b. amylase sensitive

A

a. amylase resistant

57
Q

PSSM-2
a. amylase resistant
b. amylase sensitive

A

b. amylase sensitive

58
Q

Myotonia congenita
a. RYR-1
b. SCN4A
c. CLCN1
d. CIAM

59
Q

Adiponectin
a. insulin-sensitizing hormone
b. insulin desentisizing hormone

A

a. insulin-sensitizing hormone

60
Q

Leptin in IR
a. higher
b. normal
c. lower

61
Q

Glutamate
a. inhibitory neurotransmitter
b. excitatory neurotransmitter

A

b. excitatory neurotransmitter

62
Q

Aspartate
a. inhibitory neurotransmitter
b. excitatory neurotransmitter

A

b. excitatory neurotransmitter

63
Q

Acetylcholine
a. inhibitory neurotransmitter
b. excitatory neurotransmitter

A

b. excitatory neurotransmitter

64
Q

GABA
a. inhibitory neurotransmitter
b. excitatory neurotransmitter

A

a. inhibitory neurotransmitter

65
Q

Glycine
a. inhibitory neurotransmitter
b. excitatory neurotransmitter

A

a. inhibitory neurotransmitter

66
Q

Taurine
a. inhibitory neurotransmitter
b. excitatory neurotransmitter

A

a. inhibitory neurotransmitter

67
Q

Norepinephrine
a. inhibitory neurotransmitter
b. excitatory neurotransmitter

A

a. inhibitory neurotransmitter

68
Q

Prehension/swallowing
a. V, VII, IX, XII
b. V, VII, IX, X, XII
c. VII, IX, X, XI, XII
d. V, VII, IX, X, XI, XII

A

d. V, VII, IX, X, XI, XII

69
Q

THO
a. VII, VIII
b. IX, X
c. VII, VIII, IX
d. VII, VIII, IX, X

A

d. VII, VIII, IX, X

70
Q

Slaframine
a. Ranusei solifra
b. Rinasi sercumsepti
c. Rhinofalei surrati
d. Rhizoctonia leguminicola

A

d. Rhizoctonia leguminicola

71
Q

EAdV1
a. ubiquitous
b. only in respiratory disease and diarrhea

A

a. ubiquitous

72
Q

EAdV2
a. ubiquitous
b. only in respiratory disease and diarrhea

A

b. only in respiratory disease and diarrhea

73
Q

Leptin
a. increases after meal
b. same after meal
c. decreases after meal

A

a. increases after meal

74
Q

Correlation with total body fat
a. Leptin / adiponectin positively correlated
b. Leptin positively correlated, adiponectin negatively correlated
c. Leptin negatively correlated, adiponectin positively correlated
d. Leptin / adiponectin negatively correlated

A

b. Leptin positively correlated, adiponectin negatively correlated

75
Q

Primary bile acids
a. cholate and chenodeoxycholate
b. cholate and lithocholate
c. deoxycholate and lithocholate
d. deoxycholate and chenodeoxychoalte

A

a. cholate and chenodeoxycholate

76
Q

Secondary bile acids
a. cholate and chenodeoxycholate
b. cholate and lithocholate
c. deoxycholate and lithocholate
d. deoxycholate and chenodeoxychoalte

A

c. deoxycholate and lithocholate

77
Q

Aldosterone
a. Na retention
b. Na and H2O retention
c. Na excretion
d. Na and H2O extrection

A

b. Na and H2O retention

78
Q

Lipase
a. excretion VLDL by liver
b. excretion VLDL by adipose tissue
c. uptake VLDL by adipose tissue
d. lipolysis adipose tissue

A

c. uptake VLDL by adipose tissue

79
Q

Hormone-sensitive lipase
a. excretion VLDL by liver
b. excretion VLDL by adipose tissue
c. uptake VLDL by adipose tissue
d. lipolysis adipose tissue

A

d. lipolysis adipose tissue

80
Q

Lipemia –> creatinine
a. decrease
b. increase
c. falsely decrease
d. falsely increase

A

d. falsely increase

81
Q

Reactive/secondary systemic amyloidosis
a. SAA
b. amyloid light-chain fibrils

82
Q

Systemic primary, immunocytic, or idiopathic amyloidosis
a. SAA
b. amyloid light-chain fibrils

A

b. amyloid light-chain fibrils

83
Q

Most common VSD
a. perimembranous between aortic and tricuspid valve
b. double committed between aortic and pulmonary valves
c. muscular
d. TOF

A

a. perimembranous between aortic and tricuspid valve

84
Q

TOF
a. left ventricular outflow obstruction, left ventricular hypertrophy, VSD, dexoposition aorta
b. right ventricular outflow obstruction, right ventricular hypertrophy, VSD, dexoposition aorta
c. left ventricular outflow obstruction, right ventricular hypertrophy, VSD, dexoposition aorta
d. right ventricular outflow obstruction, left ventricular hypertrophy, VSD, dexoposition aorta

A

b. right ventricular outflow obstruction, right ventricular hypertrophy, VSD, dexoposition aorta

85
Q

V200 lower
a. musculoskeletal injury
b. respiratory disease

A

a. musculoskeletal injury

86
Q

V200 lower
a. cardiovascular disease
b. respiratory disease

A

a. cardiovascular disease

87
Q

VLa4 lower
a. cardiovascular disease
b. respiratory disease
c. musculoskeletal injury

A

b. respiratory disease

88
Q

Class I antiarrhytmic agents
a. Na-channel blockers
b. Ca-channel blockers
c. K-channel blockers
d. bèta-adrenoceptor antagonist

A

a. Na-channel blockers

89
Q

Class II antiarrhytmic agents
a. Na-channel blockers
b. Ca-channel blockers
c. K-channel blockers
d. bèta-adrenoceptor antagonist

A

d. bèta-adrenoceptor antagonist

90
Q

Class III antiarrhytmic agents
a. Na-channel blockers
b. Ca-channel blockers
c. K-channel blockers
d. bèta-adrenoceptor antagonist

A

c. K-channel blockers

91
Q

Class IV antiarrhytmic agents
a. Na-channel blockers
b. Ca-channel blockers
c. K-channel blockers
d. bèta-adrenoceptor antagonist

A

b. Ca-channel blockers

92
Q

Quinidine
a. Na-channel blockers
b. Ca-channel blockers
c. K-channel blockers
d. bèta-adrenoceptor antagonist

A

a. Na-channel blockers

93
Q

Proceinamide
a. Na-channel blockers
b. Ca-channel blockers
c. K-channel blockers
d. bèta-adrenoceptor antagonist

A

a. Na-channel blockers

94
Q

Lidocaine
a. Na-channel blockers
b. Ca-channel blockers
c. K-channel blockers
d. bèta-adrenoceptor antagonist

A

a. Na-channel blockers

95
Q

Phenytoin
a. Na-channel blockers
b. Ca-channel blockers
c. K-channel blockers
d. bèta-adrenoceptor antagonist

A

a. Na-channel blockers

96
Q

Propanolol
a. Na-channel blockers
b. Ca-channel blockers
c. K-channel blockers
d. bèta-adrenoceptor antagonist

A

d. bèta-adrenoceptor antagonist

97
Q

Sotalol
a. Na-channel blockers
b. Ca-channel blockers
c. K-channel blockers
d. bèta-adrenoceptor antagonist

A

d. bèta-adrenoceptor antagonist

98
Q

Amiodarone
a. Na-channel blockers
b. Ca-channel blockers
c. K-channel blockers
d. bèta-adrenoceptor antagonist

A

c. K-channel blockers (> ADVERSE EFFECTS)

99
Q

Diltiazem
a. Na-channel blockers
b. Ca-channel blockers
c. K-channel blockers
d. bèta-adrenoceptor antagonist

A

b. Ca-channel blockers

100
Q

Furosemide
a. loop diuretic that inhibits reabsorption elektryolytes thick ascending loop of Henle (increased excretion Na, Cl, K and H2O)
b. potassium-sparing diuretic

A

a. loop diuretic that inhibits reabsorption elektryolytes thick ascending loop of Henle (increased excretion Na, Cl, K and H2O)

101
Q

Amiloride
a. loop diuretic that inhibits reabsorption elektryolytes thick ascending loop of Henle (increased excretion Na, Cl, K and H2O)
b. potassium-sparing diuretic

A

b. potassium-sparing diuretic

102
Q

Thiazide
a. loop diuretic that inhibits reabsorption elektryolytes thick ascending loop of Henle (increased excretion Na, Cl, K and H2O)
b. potassium-sparing diuretic

A

b. potassium-sparing diureticA

103
Q

Amiloride
a. inhibit Na-selective channels in late DCT and CD
b. Inhibit Na/Cl symporter in DCT
c. act as aldosterone agonist
d. ACE inhibitor

A

a. inhibit Na-selective channels in late DCT and CD

104
Q

Thiazide
a. inhibit Na-selective channels in late DCT and CD
b. Inhibit Na/Cl symporter in DCT
c. act as aldosterone agonist
d. ACE inhibitor

A

b. Inhibit Na/Cl symporter in DCT

105
Q

Mineralocorticoid inhibitor
a. loop diuretic that inhibits reabsorption elektryolytes thick ascending loop of Henle (increased excretion Na, Cl, K and H2O)
b. potassium-sparing diuretic

A

b. potassium-sparing diuretic

106
Q

Mineralocorticoid inhibitor
a. inhibit Na-selective channels in late DCT and CD
b. Inhibit Na/Cl symporter in DCT
c. act as aldosterone agonist
d. ACE inhibitor

A

c. act as aldosterone agonist

107
Q

Benazepril
a. inhibit Na-selective channels in late DCT and CD
b. Inhibit Na/Cl symporter in DCT
c. act as aldosterone agonist
d. ACE inhibitor

A

d. ACE inhibitor

108
Q

ACE inhibitor
a. blocks renin –> angiotensin I
b. blocks angiotensin I –> angiotensin II
c. blocks angiotensin II –> aldosterone
d. bllocks angiotensin –> stimulation ADH

A

b. blocks angiotensin I –> angiotensin II

109
Q

Digoxin
a. cardiac glycoside
b. positive inotrope
c. inhibition Na/K ATPase
d. all above

A

d. all above

110
Q

Order
a. AV node –> bundle branches –> His bundle –> Purkinje system
b. AV node –> Purkinje system –> bundle branches –> His bundle
c. AV node –> His bundle –> Purkinje system –> bundle branches
d. AV node –> His bundle –> bundle branches –> Purkinje system

A

d. AV node –> His bundle –> bundle branches –> Purkinje system

111
Q

Ta wave
a. ventricular depolarization
b. ventricular repolarization
c. atrial depolarization
d. atrial repolarization

A

d. atrial repolarization

112
Q

Hyperalgesia
a. increased response to noxious stimulous (primary or secondary in surrounding undamaged tissue)
b. increased sensitivity to nonnoxious stimuli
c. exaggerated pain sensation to nociceptive stimuli
d. pain produced by nonnoxious stimuli

A

a. increased response to noxious stimulous (primary or secondary in surrounding undamaged tissue)

113
Q

Allodynia
a. increased response to noxious stimulous (primary or secondary in surrounding undamaged tissue)
b. increased sensitivity to nonnoxious stimuli
c. exaggerated pain sensation to nociceptive stimuli
d. pain produced by nonnoxious stimuli

A

d. pain produced by nonnoxious stimuli

113
Q

Hyperpathie
a. increased response to noxious stimulous (primary or secondary in surrounding undamaged tissue)
b. increased sensitivity to nonnoxious stimuli
c. exaggerated pain sensation to nociceptive stimuli
d. pain produced by nonnoxious stimuli

A

c. exaggerated pain sensation to nociceptive stimuli

114
Q

Hyperesthesia
a. increased response to noxious stimulous (primary or secondary in surrounding undamaged tissue)
b. increased sensitivity to nonnoxious stimuli
c. exaggerated pain sensation to nociceptive stimuli
d. pain produced by nonnoxious stimuli

A

b. increased sensitivity to nonnoxious stimuli

General (18 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions